Exclusive

Publication

Byline

Location

US Patent Issued to Paragon Therapeutics on July 7 for "PD-1 binding proteins, VEGF and PD-1 bispecific binding proteins, compositions, and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,997, issued on July 7, was assigned to Paragon Therapeutics Inc. (Waltham, Mass.). "PD-1 binding proteins, VEGF and PD-1 bispecific binding ... Read More


US Patent Issued to Acceleron Pharma on July 7 for "ALK7 binding proteins and uses thereof" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,998, issued on July 7, was assigned to Acceleron Pharma Inc. (Rahway, N.J.). "ALK7 binding proteins and uses thereof" was invented by John K... Read More


US Patent Issued to Roche Diagnostics Operations on July 7 for "Anti-CSF-IR antibody" (German Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,999, issued on July 7, was assigned to Roche Diagnostics Operations Inc. (Indianapolis). "Anti-CSF-IR antibody" was invented by David Casago... Read More


US Patent Issued to Juno Therapeutics on July 7 for "Antibodies and chimeric antigen receptors specific for CD19" (Washington Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,000, issued on July 7, was assigned to Juno Therapeutics Inc. (Seattle). "Antibodies and chimeric antigen receptors specific for CD19" was i... Read More


US Patent Issued to GENMAB on July 7 for "Method of treating cancer by administering an antibody which binds to 5T4" (Dutch, American Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,001, issued on July 7, was assigned to GENMAB A/S (Valby, Denmark). "Method of treating cancer by administering an antibody which binds to 5... Read More


US Patent Issued to The Johns Hopkins University on July 7 for "MANAbodies targeting tumor antigens and methods of using" (Maryland, Washington, Delaware Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,002, issued on July 7, was assigned to The Johns Hopkins University (Baltimore). "MANAbodies targeting tumor antigens and methods of using" ... Read More


US Patent Issued to Genzyme on July 7 for "Site-specific glycoengineering of targeting moieties" (Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,003, issued on July 7, was assigned to Genzyme Corp. (Cambridge, Mass.). "Site-specific glycoengineering of targeting moieties" was invented... Read More


US Patent Issued to UNIVERSITETET I OSLO on July 7 for "Engineered immunoglobulins with altered FcRn binding" (Norwegian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,004, issued on July 7, was assigned to UNIVERSITETET I OSLO (Oslo, Norway). "Engineered immunoglobulins with altered FcRn binding" was inven... Read More


US Patent Issued to CyDex Pharmaceuticals on July 7 for "Alkylated cyclodextrin compositions and processes for preparing and using the same" (Kansas Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,005, issued on July 7, was assigned to CyDex Pharmaceuticals Inc. (Lawrence, Kan.). "Alkylated cyclodextrin compositions and processes for p... Read More


US Patent Issued to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE GRENOBLE ALPES on July 7 for "Modified hyaluronic acid as dopant for PEDOT and/or PProDOT polymers" (French Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,006, issued on July 7, was assigned to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (Paris), CENTRE NATIONAL DE LA RECHERCH... Read More